20 December 2023
GOODWIN PLC CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS for the half year ended 31st October 2023 CHAIRMAN’S STATEMENT I am pleased to report our half-year…
18 December 2023
Jemperli (dostarlimab) plus Zejula (niraparib) combination significantly improved progression-free survival in primary advanced or recurrent endometrial cancer in RUBY Part 2 Phase III trial · Dostarlimab plus chemotherapy…
13 December 2023
NWF Group plc NWF Group plc: Trading Update NWF Group plc (‘NWF’ the ‘Company’ or the ‘Group’), the specialist distributor today provides a trading…
LONDON STOCK EXCHANGE ANNOUNCEMENT JPMORGAN INDIAN INVESTMENT TRUST PLC (the ‘Company’) FINAL RESULTS FOR THE YEAR ENDED 30TH SEPTEMBER 2023 Legal Entity Identifier: 549300OHW8R1C2WBYK02…
13 December 2023 TREATT PLC (“Treatt”, the “Company” or “the Group”) Interim Chief Financial Officer Appointment Treatt, the manufacturer and supplier of a diverse…
RUFFER INVESTMENT COMPANY LIMITED (a closed-ended investment company incorporated in Guernsey with registration number 41996) LEI 21380068AHZKY7MKNO47 Attached is a link to the Monthly…
12 December 2023
Japan’s Ministry of Health, Labour and Welfare accepts Arexvy regulatory application to prevent RSV disease in adults aged 50-59 at increased risk · Submission supported by…
12 December 2023 AstraZeneca to acquire Icosavax, including potential first-in-class RSV and hMPV combination vaccine with positive Phase II data Building on expertise in…